Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (401-410 of 578) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|July 1, 2025
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancerKristina Lindemann, Dominique Berton, Jalid Sehouli, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
British Journal of Cancer|October 25, 2018
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapyMichael Friedlander, Ursula Matulonis, Charlie Gourley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.
NPJ Genomic Medicine|April 28, 2022
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancerAdriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar CancerMaaike H M Oonk, François Planchamp, Peter Baldwin, et al.
British Journal of Cancer|June 30, 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
The European Network for Gynaecological Oncological Trial Groups Charta for Privileged PartnershipChristian Marth, Andreas du Bois, Christian Schauer, et al.
Pageof 58

Showing results (401-410 of 578) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|July 1, 2025
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancerKristina Lindemann, Dominique Berton, Jalid Sehouli, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
British Journal of Cancer|October 25, 2018
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapyMichael Friedlander, Ursula Matulonis, Charlie Gourley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.
NPJ Genomic Medicine|April 28, 2022
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancerAdriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar CancerMaaike H M Oonk, François Planchamp, Peter Baldwin, et al.
British Journal of Cancer|June 30, 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
The European Network for Gynaecological Oncological Trial Groups Charta for Privileged PartnershipChristian Marth, Andreas du Bois, Christian Schauer, et al.
Pageof 58